Bleeding risk comparison between direct oral anticoagulants at doses approved for atrial fibrillation and aspirin: systematic review, meta-analysis and meta-regression

D Sagris, I Leventis, G Georgiopoulos… - European Journal of …, 2020 - Elsevier
Background A considerable proportion of patients with atrial fibrillation (AF) are still treated
with aspirin despite current guidelines due to presumed favorable safety. Aim We performed …
被引用次数：11 相关文章

Bleeding risk comparison between direct oral anticoagulants at doses approved for atrial fibrillation and aspirin: systematic review, meta-analysis and meta-regression …

D Sagris, I Leventis, G Georgiopoulos… - European Journal of …, 2020 - europepmc.org
Background A considerable proportion of patients with atrial fibrillation (AF) are still treated
with aspirin despite current guidelines due to presumed favorable safety. Aim We performed …

Bleeding risk comparison between direct oral anticoagulants at doses approved for atrial fibrillation and aspirin: systematic review, meta-analysis and meta-regression

D Sagris, I Leventis, G Georgiopoulos… - European Journal of …, 2020 - kclpure.kcl.ac.uk
Background: A considerable proportion of patients with atrial fibrillation (AF) are still treated
with aspirin despite current guidelines due to presumed favorable safety. Aim: We performed …

Bleeding risk comparison between direct oral anticoagulants at doses approved for atrial fibrillation and aspirin: systematic review, meta-analysis and meta-regression

D Sagris, I Leventis… - … journal of internal …, 2020 - pubmed.ncbi.nlm.nih.gov
Background A considerable proportion of patients with atrial fibrillation (AF) are still treated
with aspirin despite current guidelines due to presumed favorable safety. Aim We performed …

Bleeding risk comparison between direct oral anticoagulants at doses approved for atrial fibrillation and aspirin: systematic review, meta-analysis and meta-regression

D Sagris, I Leventis, G Georgiopoulos… - European Journal of …, 2020 - ejinme.com
Background A considerable proportion of patients with atrial fibrillation (AF) are still treated
with aspirin despite current guidelines due to presumed favorable safety. Aim We performed …

Bleeding risk comparison between direct oral anticoagulants at doses approved for atrial fibrillation and aspirin: systematic review, meta-analysis and meta-regression

D Sagris, I Leventis, G Georgiopoulos, E Korompoki… - 2020 - ir.lib.uth.gr
Background: A considerable proportion of patients with atrial fibrillation (AF) are still treated
with aspirin despite current guidelines due to presumed favorable safety. Aim: We performed …

Bleeding risk comparison between direct oral anticoagulants at doses approved for atrial fibrillation and aspirin: systematic review, meta-analysis and meta-regression

D Sagris, I Leventis, G Georgiopoulos… - European Journal of …, 2020 - vbn.aau.dk
BACKGROUND: A considerable proportion of patients with atrial fibrillation (AF) are still
treated with aspirin despite current guidelines due to presumed favorable safety. AIM: We …